Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa

Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa

Abstract Background In 2011, South Africa improved its ability to test for rifampicin-resistant TB (RR-TB) by introducing GeneXpert MTB/RIF. At the same time, the South African National TB program adopted a policy decentralized, outpatient treatment for drug resistant (DR-) TB. We aim to analyze the...

Full description

Bibliographic Details
Main Authors: Denise Evans, Tembeka Sineke, Kathryn Schnippel, Rebecca Berhanu, Caroline Govathson, Andrew Black, Lawrence Long, Sydney Rosen
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Health Services Research
Subjects:
Rifampicin resistance
South Africa
Time to treatment initiation
Decentralization
Xpert MTB/RIF
HIV positive
Online Access:http://link.springer.com/article/10.1186/s12913-018-3762-x

Internet

http://link.springer.com/article/10.1186/s12913-018-3762-x

Similar Items